BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22406037)

  • 21. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research.
    Eapen M; Zhang MJ; Devidas M; Raetz E; Barredo JC; Ritchey AK; Godder K; Grupp S; Lewis VA; Malloy K; Carroll WL; Davies SM; Camitta BM; ;
    Leukemia; 2008 Feb; 22(2):281-6. PubMed ID: 18033318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission.
    Page KM; Labopin M; Ruggeri A; Michel G; Diaz de Heredia C; O'Brien T; Picardi A; Ayas M; Bittencourt H; Vora AJ; Troy J; Bonfim C; Volt F; Gluckman E; Bader P; Kurtzberg J; Rocha V
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1350-1358. PubMed ID: 28438676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia.
    Atsuta Y; Morishima Y; Suzuki R; Nagamura-Inoue T; Taniguchi S; Takahashi S; Kai S; Sakamaki H; Kouzai Y; Kobayashi N; Fukuda T; Azuma H; Takanashi M; Mori T; Tsuchida M; Kawase T; Kawa K; Kodera Y; Kato S;
    Biol Blood Marrow Transplant; 2012 May; 18(5):780-7. PubMed ID: 22008851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.
    Barker JN; Davies SM; DeFor T; Ramsay NK; Weisdorf DJ; Wagner JE
    Blood; 2001 May; 97(10):2957-61. PubMed ID: 11342417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.
    Arora M; Weisdorf DJ; Spellman SR; Haagenson MD; Klein JP; Hurley CK; Selby GB; Antin JH; Kernan NA; Kollman C; Nademanee A; McGlave P; Horowitz MM; Petersdorf EW
    J Clin Oncol; 2009 Apr; 27(10):1644-52. PubMed ID: 19224849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Umbilical Cord Blood Transplantation without Antithymocyte Globulin Results in Similar Survival but Better Quality of Life Compared with Unrelated Peripheral Blood Stem Cell Transplantation for the Treatment of Acute Leukemia-A Retrospective Study in China.
    Tong J; Xuan L; Sun Y; Huang D; Liu H; Zheng C; Zhu X; Tang B; Song K; Zhang X; Zhang L; Yao W; Lin D; Liu Q; Sun Z
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1541-1548. PubMed ID: 28499936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.
    Weisdorf DJ; Nelson G; Lee SJ; Haagenson M; Spellman S; Antin JH; Bolwell B; Cahn JY; Cervantes F; Copelan E; Gale R; Gratwohl A; Khoury HJ; McCarthy P; Marks DI; Szer J; Woolfrey A; Cortes-Franco J; Horowitz MM; Arora M;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1475-8. PubMed ID: 19822308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cord-Blood Transplantation in Patients with Minimal Residual Disease.
    Milano F; Gooley T; Wood B; Woolfrey A; Flowers ME; Doney K; Witherspoon R; Mielcarek M; Deeg JH; Sorror M; Dahlberg A; Sandmaier BM; Salit R; Petersdorf E; Appelbaum FR; Delaney C
    N Engl J Med; 2016 Sep; 375(10):944-53. PubMed ID: 27602666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia.
    Rocha V; Ruggeri A; Spellman S; Wang T; Sobecks R; Locatelli F; Askar M; Michel G; Arcese W; Iori AP; Purtill D; Danby R; Sanz GF; Gluckman E; Eapen M;
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1284-1289. PubMed ID: 27090957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.
    Ponce DM; Hilden P; Devlin SM; Maloy M; Lubin M; Castro-Malaspina H; Dahi P; Hsu K; Jakubowski AA; Kernan NA; Koehne G; O'Reilly RJ; Papadopoulos EB; Perales MA; Sauter C; Scaradavou A; Tamari R; van den Brink MR; Young JW; Giralt S; Barker JN
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1985-93. PubMed ID: 26238810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes.
    Dalle JH; Balduzzi A; Bader P; Lankester A; Yaniv I; Wachowiak J; Pieczonka A; Bierings M; Yesilipek A; Sedlaçek P; Ifversen M; Sufliarska S; Toporski J; Glogova E; Poetschger U; Peters C
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1848-1855. PubMed ID: 29772352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.
    Gupta V; Tallman MS; He W; Logan BR; Copelan E; Gale RP; Khoury HJ; Klumpp T; Koreth J; Lazarus HM; Marks DI; Martino R; Rizzieri DA; Rowe JM; Sabloff M; Waller EK; DiPersio JF; Bunjes DW; Weisdorf DJ
    Blood; 2010 Sep; 116(11):1839-48. PubMed ID: 20538804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia.
    Keating AK; Langenhorst J; Wagner JE; Page KM; Veys P; Wynn RF; Stefanski H; Elfeky R; Giller R; Mitchell R; Milano F; O'Brien TA; Dahlberg A; Delaney C; Kurtzberg J; Verneris MR; Boelens JJ
    Blood Adv; 2019 Apr; 3(7):1118-1128. PubMed ID: 30952678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Similar outcomes of allogeneic hematopoietic cell transplantation from unrelated donor and umbilical cord blood vs. sibling donor for pediatric acute myeloid leukemia: Multicenter experience in China.
    Tang X; Chen J; Fang J; Sun X; Qin MQ; Li J; Zhu Y; Luan Z
    Pediatr Transplant; 2015 Jun; 19(4):413-21. PubMed ID: 25903451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.
    Rocha V; Cornish J; Sievers EL; Filipovich A; Locatelli F; Peters C; Remberger M; Michel G; Arcese W; Dallorso S; Tiedemann K; Busca A; Chan KW; Kato S; Ortega J; Vowels M; Zander A; Souillet G; Oakill A; Woolfrey A; Pay AL; Green A; Garnier F; Ionescu I; Wernet P; Sirchia G; Rubinstein P; Chevret S; Gluckman E
    Blood; 2001 May; 97(10):2962-71. PubMed ID: 11342418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unrelated cord blood transplantation vs. HLA-matched sibling transplantation for adults with B-cell acute lymphoblastic leukemia in complete remission: superior OS for patients with long-term survival.
    Sun G; Tang B; Song K; Wu Y; Tu M; Wan X; Yao W; Geng L; Qiang P; Zhu X
    Stem Cell Res Ther; 2022 Oct; 13(1):500. PubMed ID: 36210439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.
    Rocha V; Labopin M; Sanz G; Arcese W; Schwerdtfeger R; Bosi A; Jacobsen N; Ruutu T; de Lima M; Finke J; Frassoni F; Gluckman E; ;
    N Engl J Med; 2004 Nov; 351(22):2276-85. PubMed ID: 15564544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unrelated donor marrow transplantation in children.
    Balduzzi A; Gooley T; Anasetti C; Sanders JE; Martin PJ; Petersdorf EW; Appelbaum FR; Buckner CD; Matthews D; Storb R; Sullivan KM; Hansen JA
    Blood; 1995 Oct; 86(8):3247-56. PubMed ID: 7579422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.
    Konuma T; Tsukada N; Kanda J; Uchida N; Ohno Y; Miyakoshi S; Kanamori H; Hidaka M; Sakura T; Onizuka M; Kobayashi N; Sawa M; Eto T; Matsuhashi Y; Kato K; Ichinohe T; Atsuta Y; Miyamura K;
    Am J Hematol; 2016 May; 91(5):E284-92. PubMed ID: 26910296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.